GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, INSR, JAK2, KCNH2, KDR, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
16.5353 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TYR |
16.5353 |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.9547 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.9547 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, FABP3, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, INSR, JAK2, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TEK, TYR |
14.0609 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR5A, IGF1R, INSR, JAK2, KDR, KIT, MMP2, PIK3CA, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
13.8642 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, JAK2, KDR, KIT, MET, MGLL, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
13.005 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, JAK2, KDR, KIT, MET, MGLL, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
12.8065 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
12.604 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
12.5721 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EBP, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MET, MGLL, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
12.3324 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.1142 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
10.4889 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, DNMT1, DRD2, EGFR, ESR1, F3, FABP3, FLT3, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, JAK2, KDR, KIT, MMP2, MMP9, NUAK1, PIM1, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
10.3877 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, JAK2, KDR, KIT, MET, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
10.3634 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.269 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, INSR, JAK2, KCNH2, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TNKS2, TYR |
9.98126 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
9.94577 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, ESR1, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MGLL, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TYR |
9.93566 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EBP, FABP3, FUT7, HSPA1A, HTR2B, HTR2C, MGLL, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
9.93566 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, JAK2, PTGS2, RORC, SRC, TYR |
9.75397 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, FLT3, HSD11B2, HTR1B, HTR5A, PTGS2, RORC, SRC, TEK, TYR |
9.70223 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA3, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KCNH2, KDR, PTGS2, SRC |
9.5895 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, EGFR, ESR1, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, INSR, KIT, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
9.56773 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, JAK2, KDR, KIT, MET, MGLL, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
9.36492 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA3, CSNK2A1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPRS, SRC, TEK, TNKS, XDH |
9.09667 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
8.83305 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TYR, XDH |
8.73935 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, HTR1B, IGF1R, INSR, KCNH2, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, RORC, SMAD3, SRC, TERT |
8.63812 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA3, CSNK2A1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPRS, SRC, TEK, TNKS, XDH |
8.59226 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
8.5905 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, EGFR, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, JAK2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
8.58989 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, KIT, PIM1, SRC, TEK |
8.41092 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, GPR35, HTR2A, HTR2B, HTR2C, INSR, JAK2, KCNH2, MET, PIK3CA, PIK3CB, SMAD3 |
8.35398 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EBP, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
8.3237 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA3, ALOX15, APP, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MMP9, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
8.19078 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, JAK2, KDR, KIT, MMP2, MMP9, PIM1, PTGS2, TEK, TERT |
8.12085 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HTR2A, HTR2B, HTR2C, INSR, JAK2, KCNH2, MET, PIK3CA, PIK3CB, SMAD3, SRC, TERT |
8.10682 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC, TEK |
8.05305 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, JAK2, KDR, KIT, MET, MGLL, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
8.00544 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, JAK2 |
7.9805 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.978 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, INSR, KIT, PPARA, PTGS2, SRC, TEK |
7.94629 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
7.93447 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TYR, XDH |
7.8818 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.76736 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, HTR2B, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIM1, SRC, TEK, TNKS |
7.70121 |
[BP] GO:0007187 |
None
|
CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
7.65776 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CA3, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D, JAK2, KDR, SRC |
7.64407 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.63211 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.61232 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, KIT, MET, SRC, TEK |
7.59745 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CNR1, DRD1, DRD2, EGFR, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC, TNKS, TNKS2 |
7.56611 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, KIT, MET, SRC, TEK |
7.52718 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, KIT, MET, MGLL, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.49183 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.40545 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, HTR1D, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.36216 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, HTR2A, KIT, PTGS2 |
7.3584 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, HTR2A, KIT, PTGS2 |
7.3584 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 |
7.35544 |
[BP] GO:0003018 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK |
7.29299 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, INSR, JAK2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS2, TYR |
7.26357 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, HTR1B, HTR2A, HTR2B, KIT, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, TYR |
7.20608 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.20608 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, APP, BCL2, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
7.20608 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
7.16107 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, APP, BCL2, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
7.13071 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
7.12124 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, HTR1B, IGF1R, INSR, KDR, KIT, MMP2, PIK3CA, PTGS2, RORC, SMAD3, SRC |
7.08378 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, SRC, TEK |
7.07357 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, EGFR, F3, INSR, KIT, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
7.06365 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DNMT1, DRD1, DRD2, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
7.01319 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
6.97705 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
6.8973 |
[BP] GO:0097756 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.87662 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, APP, CNR1, CNR2, CYP19A1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, JAK2, MET, MGLL, MMP2, NUAK1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
6.86737 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, HTR2B, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TNKS |
6.84142 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
6.83715 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, EBP, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TNKS, TNKS2 |
6.79619 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 |
6.73186 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, EBP, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2 |
6.69344 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.63952 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, APP, CA2, CNR1, CNR2, DRD1, DRD2, ESR1, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, INSR, JAK2, PIK3CA, PIK3CB, SRC |
6.63183 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EBP, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, INSR, KDR, KIT, PIK3CA, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
6.62447 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, EGFR, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, JAK2, KCNH2, MMP9, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TERT |
6.5998 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.58805 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, APP, BCL2, DRD1, DRD2, EGFR, FABP3, FLT3, HTR2A, HTR2B, HTR2C, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
6.52866 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, APP, BCL2, DRD1, DRD2, EGFR, FABP3, FLT3, HTR2A, HTR2B, HTR2C, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
6.52866 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
6.52814 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DNMT1, DRD1, DRD2, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
6.51887 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 |
6.51498 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC, TEK |
6.47342 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, JAK2, KDR, KIT, PIK3CB, SRC, TEK, XDH |
6.34797 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, GPR35, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, PIK3CB, SMAD3 |
6.34506 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, JAK2, KIT, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, XDH |
6.30113 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HTR1B, JAK2, MMP2, MMP9, PTGS2, TERT |
6.29621 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F3, INSR, KIT, MET, PIK3CA, PIK3CB, SRC, TEK |
6.29131 |
[BP] GO:0003013 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK |
6.16651 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, KIT, MMP9, PTGS2, TERT |
6.1662 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
6.13324 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.13174 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, APP, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
6.02257 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, HTR1B, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MMP2, MMP9, NUAK1, PIK3CA, PTGS2, RORC, SMAD3, SRC, TERT |
6.02257 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, IGF1R, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
6.02257 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA3, APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, JAK2, KIT, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, TNKS, XDH |
5.97601 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, HTR5A, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TYR |
5.95789 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
5.94345 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, DRD2, DUSP3, EGFR, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, PIK3CB, SRC, TEK, XDH |
5.91436 |
[BP] GO:0097746 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.903 |
[BP] GO:0035296 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.903 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2, DRD2, HTR1B |
5.89449 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, APP, BCL2, DNMT1, DRD2, DYRK1A, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
5.89254 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, APP, BCL2, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
5.86964 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, PIK3CB, SMAD3 |
5.84107 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CA3, CYP1B1, EGFR, HSPA1A, JAK2, MMP9, PTGS1, PTGS2, SRC |
5.84107 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EBP, HTR1A, TYR |
5.80374 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, EGFR, PIK3CB, PTGS2, TNKS, TNKS2 |
5.78836 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DYRK1A, EGFR, ESR1, HTR7, KIT, PPARA, RORC, SRC |
5.78739 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
5.76228 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
CNR1, DRD1, DRD2, EGFR, HTR1B, HTR2A, PTGS2 |
5.7379 |
[BP] GO:0050880 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.69835 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, JAK2, PPARA, SMAD3 |
5.68753 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC, TEK |
5.68753 |
[BP] GO:0035150 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.67774 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
5.65312 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.65066 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, APP, BCL2, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
5.59313 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CNR1, CYP1A1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, RORC, SRC, TEK |
5.59021 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, JAK2, KDR, MMP9, PIK3CA, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
5.56843 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, APP, AURKB, BCL2, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
5.56806 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
5.52546 |
[BP] GO:0050795 |
None
|
CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
5.52546 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, APP, BCL2, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
5.52156 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
5.52156 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, CNR1, DRD2, GPR35, HTR1B, HTR2A, KCNH2, MMP9, PTGS2 |
5.49211 |
[BP] GO:0003008 |
None
|
AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, INSR, KCNH2, KIT, PIK3CA, PTGS2, SRC, TEK, TYR |
5.48624 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 |
5.47264 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, CNR1, DNMT1, DRD2, ESR1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
5.47186 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, BCL2, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, TEK, XDH |
5.46829 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, CNR2, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPRS, SMAD3, SRC, TERT, XDH |
5.44885 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, DRD1, DRD2, EGFR, ESR1, F3, FABP4, JAK2, KDR, MET, MGLL, PPARA, PTGS2, PTPRS, SMAD3, TEK |
5.42875 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, CNR2, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPRS, SMAD3, SRC, TERT, XDH |
5.42875 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA3, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, HTR1A, HTR2C, JAK2, KIT, MGLL, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT |
5.3794 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, EGFR, HTR2A, HTR2B, HTR2C, KDR, SRC, TEK |
5.3546 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, APP, BCL2, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
5.32646 |
[BP] GO:0007610 |
None
|
APP, BCL2, CNR1, DRD1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, KIT, PPARA, PTGS2 |
5.29976 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
5.29484 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
5.26566 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALOX15, APP, BCL2, DNMT1, DRD2, DYRK1A, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, JAK2, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
5.25843 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, PIK3CB, SMAD3 |
5.25172 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.24228 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, JAK2, MMP2, MMP9, TERT |
5.18957 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2 |
5.18008 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.16364 |
[BP] GO:0007188 |
None
|
CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
5.16364 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC |
5.16364 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
5.15568 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
5.08703 |
[BP] GO:0007193 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
5.06879 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, JAK2, KDR, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
5.05595 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, DUSP3, EGFR, HTR2A, HTR2B, HTR2C, KDR, SRC, TEK |
5.05234 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, HTR1A, KIT, MET, PIK3CB, PIM1, SRC, TEK, TYR |
5.04316 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, JAK2, KDR, SRC |
4.99169 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
4.98534 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CB, SMAD3 |
4.9716 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
4.94163 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, APP, AURKB, BCL2, DRD2, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, JAK2, KIT, MET, MMP9, PIK3CA, PIK3CB, SMAD3, SRC, TEK, TERT, TNKS, XDH |
4.8986 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, DUSP3, ESR1, FABP4, GPR35, IGF1R, JAK2, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TNKS |
4.8903 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, SMAD3, SRC, TEK |
4.87968 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
4.80918 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, EBP, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.77369 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, MGLL, PPARA, PTGS1, PTGS2 |
4.74289 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ESR1, F3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP9, PIK3CA, PIM1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS2, XDH |
4.73031 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HTR1B, JAK2, MMP2, MMP9, PTGS2, TERT |
4.72874 |
[BP] GO:0031347 |
regulation of defense response
|
CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, JAK2, MGLL, MMP2, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK |
4.72123 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.7088 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.7088 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, APP, BCL2, CA2, CA7, CNR1, DRD1, DRD2, GPR35, HTR1A, HTR1B, HTR2A, KCNH2, MMP9, PTGS2 |
4.70281 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CB, SMAD3 |
4.55702 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
4.55702 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
4.50657 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, BCL2, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, KCNH2, PIK3CB, SMAD3 |
4.50657 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, JAK2, KDR, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
4.50085 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TYR, XDH |
4.49493 |
[BP] GO:0050727 |
regulation of inflammatory response
|
CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, JAK2, MGLL, PPARA, PTGS2, SMAD3, TEK |
4.48433 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, JAK2, KDR, KIT, MET, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
4.48387 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.48023 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CB, SMAD3 |
4.43069 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, EGFR, HTR1A, INSR, JAK2, PTGS2, SMAD3 |
4.41711 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.40445 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CB, SMAD3 |
4.37786 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HTR2A, HTR2B, HTR2C, SRC, TNKS, TNKS2 |
4.3716 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
4.34984 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, APP, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
4.34984 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CA, PIK3CB, SMAD3 |
4.34223 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CB, SMAD3 |
4.32768 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TYR, XDH |
4.32711 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, KIT, MET, MGLL, PIK3CA, PIK3CB |
4.32504 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DNMT1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
4.29472 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DNMT1, DRD1, DRD2, EGFR, HTR2A, HTR2B, HTR5A, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, SRC, TEK |
4.23426 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.23426 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, HTR2B, INSR, JAK2, KCNH2, PTGS2, SMAD3, SRC, TERT |
4.23001 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CB, SMAD3 |
4.21527 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, JAK2, KIT, PIK3CB, SRC |
4.2095 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, F3, HSPA1A, HTR2A, HTR2B, JAK2, KDR, KIT, MET, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
4.20704 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
4.18123 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, JAK2, MET, MMP9, PPARA, SMAD3, SRC, TERT, TNKS |
4.1788 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
APP, AURKB, BCL2, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, JAK2, KIT, PIK3CA, PIK3CB, SMAD3, SRC, TEK, TERT, TNKS, XDH |
4.17808 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
4.16645 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FLT3, FUT7, HSPA1A, HTR1A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
4.14878 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.14079 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, KIT, MET, SRC, TEK, TNKS |
4.1367 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DNMT1, DRD1, EGFR, ESR1, FLT3, HTR1B, IGF1R, INSR, KIT, MMP2, PTGS2, SMAD3, SRC |
4.1367 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
4.11163 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC |
4.09719 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, HTR1B, KCNH2, KDR, PTGS2, SRC |
4.07517 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.06602 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
4.0539 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
HTR1B, JAK2, MMP2, MMP9, TERT |
4.03009 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.99189 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1, RORC |
3.99189 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.9542 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
3.95271 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
3.95271 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, JAK2, KIT, PIK3CA, PIK3CB, SRC, TEK, TNKS |
3.9487 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR1D, HTR2B |
3.94545 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3 |
3.93295 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3 |
3.93295 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, JAK2, PTGS2, SMAD3, XDH |
3.91814 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
3.83474 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, F3, HTR2A, HTR2C, INSR, JAK2, KDR, KIT, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
3.82861 |
[BP] GO:0007611 |
None
|
APP, CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, KIT, PTGS2 |
3.82532 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, JAK2, KDR, KIT, MMP1, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, TUBB3 |
3.81638 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A, TYR |
3.81282 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, EGFR, HTR2B, TERT |
3.79037 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ESR1, F3, HTR2A, HTR2C, INSR, JAK2, KDR, KIT, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS2, XDH |
3.77069 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
3.72558 |
[BP] GO:0043549 |
regulation of kinase activity
|
APP, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, JAK2, KIT, PIK3CA, PIK3CB, SRC, TEK |
3.69122 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, EGFR, HTR1B, IGF1R, INSR, MMP2, PTGS2, SRC |
3.6449 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, JAK2, PTGS2, SMAD3, SRC, TERT |
3.64279 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALOX15, APP, BCL2, CSNK2A1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
3.62302 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, MET, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TNKS, TNKS2 |
3.60807 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP4, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
3.60162 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, JAK2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.60093 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CB, SMAD3 |
3.58688 |
[BP] GO:0007154 |
None
|
AXL, BCL2, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2, TEK |
3.57756 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.57756 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
3.57729 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
3.56037 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A, MET |
3.50694 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3, XDH |
3.48004 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, JAK2, KIT, PIK3CA, PIK3CB, SRC, TEK, TNKS |
3.46608 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.46401 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3 |
3.45889 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, PIK3CA, PIK3CB, SMAD3 |
3.45723 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
EGFR, FLT3, HTR2A, HTR2B, INSR, JAK2, KIT, PIK3CB, SRC |
3.454 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
APP, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, JAK2, KIT, PIK3CA, PIK3CB, SRC |
3.44005 |
[BP] GO:0023052 |
None
|
CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, KCNH2, TEK |
3.38109 |
[BP] GO:0050890 |
None
|
APP, CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, KIT, PTGS2 |
3.35461 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.35133 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, EGFR, HTR1B, IGF1R, INSR, MMP2, PTGS2, SRC |
3.35092 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, EGFR, HTR2B, TERT |
3.3494 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, JAK2, MMP9, PTGS2, SMAD3, SRC, XDH |
3.33985 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DUSP3, DYRK1A, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, SRC, XDH |
3.33635 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
3.33467 |
[BP] GO:0044057 |
None
|
ADORA3, DRD2, EGFR, GPR35, HTR2A, HTR2C, JAK2, KCNH2, KIT, MGLL, PTGS2, SMAD3 |
3.32207 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, KIT, MMP9, TERT |
3.31837 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.31805 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, JAK2, KDR, KIT, TEK |
3.31805 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, JAK2, PTGS2, SRC |
3.30677 |
[BP] GO:0008217 |
None
|
CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2, SMAD3 |
3.30182 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3 |
3.28666 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F3, FABP4, JAK2, KDR, MET, PTGS2, SMAD3 |
3.28553 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, HSPA1A |
3.26113 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
3.2532 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, CNR1, CSNK2A1, DNMT1, DRD2, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PIK3CB, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.25197 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, MET, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TNKS, TNKS2 |
3.24816 |
[BP] GO:0006936 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA |
3.24342 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.23707 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.23707 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.23707 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.23707 |
[BP] GO:0007267 |
None
|
CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, TEK |
3.23399 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
3.23399 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.23399 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
3.23399 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2, SMAD3 |
3.23399 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, EGFR, KIT, PTGS2, TYR |
3.23399 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.19786 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.17067 |
[BP] GO:0090066 |
None
|
ALOX15, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
3.16534 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, INSR, PTGS2 |
3.15589 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
3.1394 |
[BP] GO:0006811 |
None
|
ABCB1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, HTR2A, HTR2B, HTR2C, KCNH2, PPARA |
3.13912 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, JAK2, KIT, PIK3CA, PIK3CB, SRC, TEK |
3.13025 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.12969 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.12969 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.12969 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.12807 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.12807 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DRD2, DUSP3, DYRK1A, ESR1, ESR2, FABP4, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP9, PIK3CA, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
3.12525 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, JAK2, PTGS2, SRC |
3.12296 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.12187 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.09988 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.08674 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.08674 |
[BP] GO:0040008 |
regulation of growth
|
APP, BCL2, CSNK2A1, DRD2, EGFR, ESR2, HSPA1A, INSR, PIK3CA, PIM1, PTPRS, SMAD3, TNKS2 |
3.07131 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
3.03828 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, EBP, FLT3, KDR, KIT, TEK, TYR |
3.03235 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.02997 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.02997 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, JAK2, KDR, KIT, TEK |
3.02906 |
[BP] GO:0002031 |
None
|
DRD2, HTR1B, HTR2B |
3.00967 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.00967 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
3.00967 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
3.00693 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, PIK3CA, TNKS2 |
3.00266 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, JAK2, MMP9, PTGS2, SMAD3, SRC, XDH |
2.98755 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.9856 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CYP1B1, DUSP3, JAK2, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK |
2.97684 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, MGLL, PPARA, PTGS1, PTGS2 |
2.97684 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.96524 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.93616 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CNR1, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, HSD11B2, HSD17B2, INSR, KIT, MMP2, MMP9, PTGS2, SRC |
2.93016 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TEK, TERT |
2.92339 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, JAK2, PIM1, PPARA, RORC, SRC |
2.92339 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR |
2.92133 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA |
2.91086 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.91011 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
2.90926 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
2.87506 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.87384 |
[BP] GO:0006952 |
defense response
|
ADORA3, ALOX15, APP, AXL, BCL2, CNR2, DRD1, HTR1A, HTR2C, JAK2, KIT, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC |
2.8695 |
[BP] GO:0051051 |
negative regulation of transport
|
APP, BCL2, CNR1, DRD2, GPR35, HSPA1A, HTR1B, HTR2A, KCNH2, MMP9, PTGS2 |
2.85913 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, JAK2 |
2.85909 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A |
2.83101 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGS1, PTGS2 |
2.81316 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, JAK2, KIT, PIK3CB, SRC |
2.81079 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.81079 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
2.81079 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
2.79343 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.79343 |
[BP] GO:0051952 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A |
2.77633 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, DUSP3, ESR1, HSPA1A, JAK2, KIT, MMP2, PIK3CA, PIK3CB, PTPRS, SMAD3, SRC |
2.77192 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, JAK2, KIT |
2.75226 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, KIT, MET, PIK3CA, PIK3CB |
2.75226 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, JAK2, KIT, PIK3CA, PIK3CB, SRC |
2.73744 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.72053 |
[BP] GO:0051967 |
None
|
DRD2, HTR1B, HTR2A |
2.72053 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, APP, AXL, BCL2, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.72053 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, JAK2, PPARA, RORC, SRC |
2.70965 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, JAK2, KIT |
2.70601 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
BCL2, CNR1, EGFR, HTR2B, MET, PIK3CA, PPARA, SMAD3 |
2.70421 |
[BP] GO:0046883 |
regulation of hormone secretion
|
CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR2A, HTR2C, JAK2 |
2.70421 |
[BP] GO:0003012 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA |
2.69353 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.68039 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
2.6684 |
[BP] GO:0006954 |
inflammatory response
|
ADORA3, ALOX15, AXL, CNR2, KIT, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.64413 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPRS, SMAD3, SRC, TERT, XDH |
2.64319 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.63871 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.63871 |
[BP] GO:1903426 |
None
|
EGFR, INSR, JAK2, PTGS2, SMAD3 |
2.63871 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CBR1, CYP1A1, DRD1, DRD2, EGFR, ESR1, FABP4, FLT3, FUT7, HTR2B, JAK2, KDR, KIT, MET, MMP2, MMP9, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT |
2.63646 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, KIT, SRC |
2.63533 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, MGLL |
2.63533 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, HTR2A, HTR2B, JAK2, KIT, MMP9, NUAK1, PTGS2, SMAD3, SRC, XDH |
2.6327 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
EGFR, FLT3, HTR2A, HTR2B, INSR, JAK2, KIT, PIK3CB, SRC |
2.62869 |
[BP] GO:0050900 |
leukocyte migration
|
CNR2, FUT7, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.62869 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, EBP, MGLL, PTGS1, PTGS2 |
2.6224 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3, JAK2 |
2.62121 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DYRK1A, EGFR, HTR7, PPARA, RORC |
2.62121 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, INSR, KIT, PTGS2 |
2.62121 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, KIT, MMP9, PIK3CA, PIK3CB, RORC, SMAD3, SRC |
2.60206 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.59385 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, FUT7, HTR2B, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIK3CA, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.59179 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
2.58023 |
[BP] GO:0060191 |
regulation of lipase activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
2.57798 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2 |
2.57396 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.57114 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.57114 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.57114 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.57114 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.57114 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
CNR2, CYP19A1, DRD1, DRD2, PPARA, PTPRS, SMAD3, TEK |
2.55406 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.52733 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.52733 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.52429 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, DYRK1A, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPRS, TERT, XDH |
2.52163 |
[BP] GO:0051341 |
None
|
CNR1, CNR2, EGFR, HTR2B, TERT |
2.51873 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CNR1, CYP1A1, DRD1, EGFR, ESR1, KIT, PTGS2, SRC |
2.51739 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
2.51178 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.51067 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.51067 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, JAK2 |
2.50427 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.50427 |
[BP] GO:0030097 |
hemopoiesis
|
EBP, FLT3, KDR, KIT, TEK |
2.50427 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR2C |
2.48198 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B |
2.47811 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DRD2, DUSP3, EGFR, INSR, SRC, TERT |
2.47689 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TNKS |
2.47193 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
2.47028 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F3, FLT3, FUT7, HTR2B, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.47028 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, KIT |
2.43681 |
[BP] GO:0023014 |
signal transduction by protein phosphorylation
|
EGFR, HTR2B, INSR, JAK2, KCNH2, KDR, KIT, MET, TEK |
2.42989 |
[BP] GO:0009888 |
tissue development
|
ALOX15, ALPL, CYP1B1, INSR, JAK2, KDR, PIK3CA, PPARA, PTGS2, RORC, SMAD3 |
2.42429 |
[BP] GO:0019637 |
organophosphate metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, HSPA1A, HTR2B, HTR2C, KIT, MET, PIK3CA, PIK3CB, PTGS2, XDH |
2.41819 |
[BP] GO:0007631 |
None
|
APP, DRD1, DRD2, HTR1B, HTR2C |
2.38417 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, SRC |
2.38417 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
APP, EGFR, JAK2, PTGS2, SMAD3, SRC, TERT |
2.38331 |
[BP] GO:0045597 |
positive regulation of cell differentiation
|
APP, AXL, BCL2, CA2, CNR1, DRD2, HTR2A, HTR2C, JAK2, KDR, KIT, PTGS2, SMAD3, TERT |
2.38303 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.3731 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, PTGS2, TEK, TERT |
2.36836 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, FUT7, HTR2B, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.36513 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, FUT7, HTR2B, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.36513 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, JAK2, SRC |
2.35217 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, CYP1B1, ESR1, ESR2, HSPA1A, JAK2, KIT, PIM1 |
2.35217 |
[BP] GO:0051052 |
regulation of DNA metabolic process
|
AURKB, DNMT1, EGFR, IGF1R, INSR, PIK3CA, SRC, TNKS, TNKS2 |
2.35217 |
[BP] GO:0050776 |
regulation of immune response
|
ALOX15, BCL2, CNR1, DRD2, DUSP3, ESR1, HSPA1A, JAK2, KIT, MMP2, PIK3CA, PIK3CB, PTPRS, SMAD3, SRC |
2.3376 |
[BP] GO:0042307 |
positive regulation of protein import into nucleus
|
APP, EGFR, JAK2, PTGS2, SMAD3 |
2.33455 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.32196 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK |
2.3203 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
2.3203 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A |
2.3203 |
[BP] GO:0033138 |
positive regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, PIK3CA, PTGS2 |
2.3203 |
[BP] GO:0046854 |
phosphatidylinositol phosphorylation
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
2.3203 |
[BP] GO:0009894 |
regulation of catabolic process
|
BCL2, CNR1, CSNK2A1, EGFR, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, SMAD3 |
2.30642 |
[BP] GO:1904591 |
positive regulation of protein import
|
APP, EGFR, JAK2, PTGS2, SMAD3 |
2.3013 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, KIT |
2.29853 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.29853 |
[BP] GO:0050730 |
None
|
APP, EGFR, FLT3, HTR2A, JAK2, KIT, SRC |
2.28841 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HTR2A, PTGS2, TERT |
2.28841 |
[BP] GO:0048638 |
regulation of developmental growth
|
APP, BCL2, DRD2, INSR, PIK3CA, PIM1, PTPRS, TNKS2 |
2.28275 |
[BP] GO:0052548 |
None
|
APP, CSNK2A1, F3, JAK2, MMP9, PTGS2, SMAD3, SRC, XDH |
2.27701 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, CYP3A4, EBP, TYR |
2.27317 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.27317 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.27317 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.27317 |
[BP] GO:0042391 |
None
|
APP, BCL2, CNR1, CNR2, DRD1, GPR35, KCNH2, KDR, SRC |
2.27285 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.2708 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.2708 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.2708 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.2708 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, BCL2, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SMAD3, SRC, TERT, TNKS |
2.2708 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.2708 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.2708 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2708 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.2708 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, HTR1B, HTR1E, HTR2A, INSR, PPARA |
2.2708 |
[BP] GO:0032147 |
activation of protein kinase activity
|
DRD2, EGFR, INSR, JAK2, KIT, PIK3CA, PIK3CB, SRC |
2.2708 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA3, APP, BCL2, CYP1B1, DRD2, FABP3, HSPA1A, JAK2, PTGS2, SMAD3, TERT, XDH |
2.26352 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, HTR1B, HTR2B |
2.25619 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CYP19A1, EGFR, ESR1, HSD17B2, INSR, KIT, PTGS2, SRC |
2.25224 |
[BP] GO:0008150 |
biological_process
|
ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
2.25134 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
2.24807 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.247 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.22101 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, JAK2, PPARA, RORC, SRC |
2.22 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, KIT, MET, PIK3CA, PIK3CB |
2.21917 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, JAK2, KDR, SMAD3, TEK |
2.21058 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, F3, JAK2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, XDH |
2.20826 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.20405 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.20405 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, HTR1B, HTR1E, HTR2A, INSR, PPARA |
2.20305 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DNMT1, DRD1, DRD2, EGFR, ESR1, ESR2, HSPA1A, HTR2A, IGF1R, INSR, MET, PPARA, RORC, SMAD3, SRC, TERT, TNKS, TNKS2 |
2.18419 |
[BP] GO:0030258 |
lipid modification
|
CYP1A1, CYP3A4, EGFR, KIT, MET, PIK3CA, PIK3CB |
2.1825 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.17933 |
[BP] GO:0008406 |
gonad development
|
BCL2, CYP19A1, ESR1, INSR, KIT |
2.17933 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, F3, JAK2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, XDH |
2.17804 |
[BP] GO:0031348 |
negative regulation of defense response
|
CNR2, CYP19A1, DRD2, PPARA, SMAD3, TEK |
2.17473 |
[BP] GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway
|
JAK2, MMP9, SMAD3 |
2.17473 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.17473 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17473 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, DRD2, EGFR, HTR2B, JAK2, PTGS2, SMAD3, SRC |
2.15901 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TEK, TERT, XDH |
2.13502 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, EGFR, KIT, PTGS2, TYR |
2.13217 |
[BP] GO:0046834 |
lipid phosphorylation
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
2.13111 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.13011 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.12566 |
[BP] GO:0007202 |
None
|
EGFR, HTR2A, HTR2B |
2.12566 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.12566 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.12566 |
[BP] GO:0051046 |
None
|
ACHE, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, JAK2, SRC |
2.11586 |
[BP] GO:0052547 |
None
|
APP, CSNK2A1, F3, JAK2, MMP9, PTGS2, SMAD3, SRC, XDH |
2.10839 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, HTR2C |
2.10152 |
[BP] GO:0050729 |
positive regulation of inflammatory response
|
CNR1, EGFR, FABP4, JAK2, PTGS2 |
2.08744 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.08744 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.08744 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.08744 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.08744 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.08744 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MGLL, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
2.08469 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.08469 |
[BP] GO:0019433 |
None
|
FABP3, FABP4, MGLL |
2.08469 |
[BP] GO:0048169 |
None
|
APP, DRD2, KIT |
2.08469 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
CNR2, CYP19A1, PPARA, SMAD3, TEK |
2.07754 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK |
2.07265 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, MGLL, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.07009 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.0439 |
[BP] GO:0060402 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.0439 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.04352 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.04352 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.04352 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.04352 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2 |
2.04352 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.0359 |
[BP] GO:0034762 |
None
|
ABCB1, APP, BCL2, CA2, DRD1, DRD2, GPR35, KCNH2, MMP9 |
2.03474 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9, RORC |
2.0321 |
[BP] GO:0051172 |
None
|
APP, AURKB, CSNK2A1, DNMT1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP4, HSPA1A, HTR1B, HTR1E, IGF1R, MMP9, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, XDH |
2.02712 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
BCL2, DRD2, GPR35, PTGS2 |
2.02557 |
[BP] GO:1901215 |
negative regulation of neuron death
|
AXL, BCL2, JAK2, PIK3CA, PPARA, TERT |
2.01414 |
[BP] GO:0045598 |
None
|
HTR2A, HTR2C, PTGS2, RORC, SMAD3 |
2.00569 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.0001 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA3, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, DUSP3, EBP, EGFR, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, PTGS2, PTPRS, SRC, TEK |
9.24484 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, APP, AXL, BACE1, CA4, CNR1, CNR2, DRD1, DRD2, EBP, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, TEK |
8.75524 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP2, PIK3CA, PIK3CB, PIM1, PTPRS, SMAD3, SRC, TEK, TERT |
8.1493 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, APP, AXL, BACE1, CNR1, CNR2, DRD1, DRD2, EBP, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, TEK |
7.8265 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA3, ALOX15, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EBP, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TYR |
7.37154 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EBP, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPRS, SRC, TEK, TYR |
6.68758 |
[CC] GO:0045121 |
membrane raft
|
APP, BACE1, CNR1, EGFR, HTR2A, INSR, JAK2, KDR, PTGS2, SRC, TEK |
4.78131 |
[CC] GO:0098857 |
membrane microdomain
|
APP, BACE1, CNR1, EGFR, HTR2A, INSR, JAK2, KDR, PTGS2, SRC, TEK |
4.75565 |
[CC] GO:0098589 |
membrane region
|
APP, BACE1, CNR1, EGFR, HTR2A, INSR, JAK2, KDR, PTGS2, SRC, TEK |
4.06602 |
[CC] GO:0005901 |
caveola
|
HTR2A, INSR, JAK2, PTGS2, SRC |
2.90133 |
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA4, CA9, CNR1, CNR2, CYP3A4, DRD1, DRD2, EBP, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, PTPRS, TEK, TYR |
2.81287 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EBP, EGFR, HSD11B1, HSD11B2, HSD17B2, MGLL, PTGS1, PTGS2 |
2.78502 |
[CC] GO:0030424 |
None
|
APP, BACE1, CA2, CNR1, DRD2, HTR2A, PTPRS, TUBB3 |
2.76427 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EBP, EGFR, FLT3, HSD11B1, HSD11B2, HSD17B2, MGLL, PTGS1, PTGS2 |
2.71146 |
[CC] GO:0120025 |
None
|
AKR1B1, APP, BACE1, CA2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, SRC, TEK, TUBB3 |
2.64283 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, BACE1, CA4, EGFR, F3, KCNH2, MET, TEK |
2.56705 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, CA2, CA4, CA9, CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, JAK2, MET, PTGS2, SRC, TEK |
2.52163 |
[CC] GO:0016021 |
None
|
ABCB1, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA9, CNR1, CNR2, CYP3A4, DRD1, DRD2, EBP, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, PTPRS, TEK, TYR |
2.46591 |
[CC] GO:0044853 |
plasma membrane raft
|
HTR2A, INSR, JAK2, PTGS2, SRC |
2.46526 |
[CC] GO:0042995 |
cell projection
|
AKR1B1, APP, BACE1, CA2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, SRC, TEK, TUBB3 |
2.38331 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AURKB, BACE1, BCL2, CA2, CA3, CA4, CA5A, CA5B, CA7, CBR1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2A, HTR4, HTR5A, INSR, JAK2, KCNH2, KDR, KIT, MGLL, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPRS, SMAD3, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.35576 |
[CC] GO:0043005 |
None
|
APP, BACE1, CA2, CNR1, CNR2, DRD2, HTR2A, HTR2B, HTR5A, PTGS2, PTPRS, SRC, TUBB3 |
2.33875 |
[CC] GO:0044464 |
cell part
|
ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA7, CA9, CBR1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
2.08744 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, JAK2, KDR, KIT, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
16.5353 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.1861 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.9547 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.9547 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
15.9547 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
15.9547 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.499 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.1639 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, RORC, SMAD3, TNKS, TYR, XDH |
12.8065 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BACE1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DUSP3, DYRK1A, EBP, EGFR, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPRS, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
12.5721 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
11.9724 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EBP, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
11.65 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
11.341 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, EGFR, FLT3, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, JAK2, KDR, KIT, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TEK |
10.484 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
10.3877 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EBP, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
10.269 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.182 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, ESR1, ESR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, JAK2, KIT, MMP1, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, RORC, SMAD3, TERT, TNKS, TNKS2, TYR, XDH |
9.97603 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EBP, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
9.94637 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EBP, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, SMAD3, TEK |
9.9425 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
8.92638 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EBP, EGFR, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, TEK |
8.85245 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EBP, EGFR, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, TEK |
8.85245 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.26007 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, KIT, MET, SRC, TEK |
7.70202 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
7.42687 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, JAK2, PIK3CA, PIK3CB |
6.69344 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DNMT1, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, RORC, SMAD3, TNKS |
6.58875 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.55724 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
6.50007 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
6.08844 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, JAK2, PTGS1, PTGS2, SRC |
5.8018 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
5.59021 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, JAK2, PTGS1, PTGS2, SRC |
5.55995 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
5.55995 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TERT |
5.18827 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR, KIT |
5.16364 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.10241 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.84346 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
4.53945 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DRD2, DYRK1A, EGFR, ESR1, ESR2, FLT3, IGF1R, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP9, NQO2, PTGS2, SMAD3, TERT, TYR, XDH |
4.33536 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, JAK2, NQO2, PTGS1, PTGS2, SRC, XDH |
4.32711 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, APP, AURKB, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, ESR1, ESR2, JAK2, KIT, MMP1, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, RORC, SMAD3, TERT, TNKS, TNKS2, TYR, XDH |
4.18242 |
[MF] GO:0004930 |
None
|
ADORA3, CNR1, CNR2, DRD1, DRD2, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
4.17554 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, TYR |
4.16645 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.07517 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, EGFR, ESR1, ESR2, FLT3, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, JAK2, KDR, KIT, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TUBB3, XDH |
3.89483 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.88183 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.74383 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2 |
3.60807 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, HSD11B2, HSD17B1, RORC |
3.58407 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TUBB3, XDH |
3.53099 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TUBB3, XDH |
3.52858 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.35461 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTPRS, SRC, TEK, TUBB3, XDH |
3.32002 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.28151 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DYRK1A, EGFR, ESR1, ESR2, FLT3, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, JAK2, KDR, KIT, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TUBB3, XDH |
3.26331 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.24855 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TUBB3, XDH |
3.21139 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.17948 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR, JAK2 |
3.17948 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
3.02906 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
2.96521 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
2.94788 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.91011 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.91011 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.91011 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.91011 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
2.84011 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
2.82224 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
2.80742 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.51067 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.51067 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.51067 |
[MF] GO:0003674 |
molecular_function
|
ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EBP, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MGLL, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
2.42204 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, RORC |
2.40665 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.40665 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC |
2.3821 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, CSNK2A1, DUSP3, DYRK1A, EGFR, F3, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PTPRS, SRC, TEK |
2.36474 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, BCL2, DRD2, FLT3, KCNH2, KIT, MGLL, NQO2, PTGS2, SMAD3, TERT, TYR, XDH |
2.33875 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TUBB3 |
2.3203 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.3203 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.2708 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.2708 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.2708 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.2708 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.17933 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.15551 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTPRS, SRC, TEK, TUBB3 |
2.11511 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.08744 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.08744 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.08744 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, BACE1, BCL2, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, F3, HSPA1A, JAK2, KCNH2, KIT, MET, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS2 |
2.08307 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TUBB3 |
2.06649 |
[MF] GO:0017076 |
purine nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TUBB3 |
2.04944 |
[MF] GO:0032553 |
ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, KIT, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TUBB3 |
2.0454 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.04352 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.0001 |